Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Is There a Role for Stimulants in Beating Cancer Fatigue?

2.

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.

3.

Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.

4.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

5.

Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot